A detailed history of West Paces Advisors Inc. transactions in Viatris Inc stock. As of the latest transaction made, West Paces Advisors Inc. holds 29 shares of VTRS stock, worth $359. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29
Previous 29 -0.0%
Holding current value
$359
Previous $308,000 9.42%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Dec 18, 2023

SELL
$9.59 - $11.35 $326 - $385
-34 Reduced 53.97%
29 $286,000
Q1 2023

Dec 18, 2023

SELL
$9.2 - $12.26 $6,964 - $9,280
-757 Reduced 92.32%
63 $606,000
Q4 2022

Dec 18, 2023

BUY
$8.72 - $11.56 $7,150 - $9,479
820 New
820 $9.13 Million
Q2 2022

Dec 18, 2023

SELL
$9.95 - $12.27 $348 - $429
-35 Reduced 35.71%
63 $660,000
Q1 2022

Dec 18, 2023

BUY
$9.81 - $15.4 $676 - $1,062
69 Added 237.93%
98 $1.07 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track West Paces Advisors Inc. Portfolio

Follow West Paces Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.